GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy

Memorial Sloan Kettering Cancer Center (MSK)

Status: Terminated

Conditions: Breast Cancer

Treatments: Other: GlowCap device

Study type: Observational

Funder types: Other

Identifiers

NCT01239251

10-183

Details and patient eligibility

About

The purpose of this study is to test the ease of using a new device, called the GlowCap that reminds the patient to take their breast cancer hormone pill. The study will collect information about the experience with this device and what the patient thinks of its role in the daily pill taking routine.

Enrollment: 8 patients

Sex: Female

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Early stage breast cancer patients taking adjuvant endocrine therapy (ie, tamoxifen, anastrozole, letrozole, exemestane).
• Age ≥ 60 years
• Must have broadband internet access at home (to enable the base for the system to communicate to the Vitality server).
• Must have a landline or mobile phone

Exclusion criteria

• Non-English speaking patients

Trial design

8 participants in 1 patient group

breast cancer patients taking endocrine therapy

Description:

Breast cancer patients, currently taking adjuvant endocrine therapy will be equipped with a GlowCap device for a period of 30 days. The GlowCap will become part of their medication taking routine.

Treatment:

Other: GlowCap device